Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitux is a Norwegian-based biotechnology and contract manufacturing organization (CMO) specializing in advanced delivery systems for the nutraceutical industry. The company is the developer of the patented ConCordix technology, a unique delivery format that transforms dietary supplements into easy-to-consume soft jellies. This technology utilizes a pre-emulsified matrix that mimics the structure of food, significantly enhancing the bioavailability of active ingredients like Omega-3 fatty acids and vitamins. Vitux provides end-to-end manufacturing services, allowing global brands to offer high-dosage, sugar-free, and shelf-stable chewable products. With GMP-certified facilities in Norway and a recently established site in Canada, the company serves a diverse international market focusing on pediatric, geriatric, and general wellness segments. Their approach effectively addresses common consumer barriers such as pill fatigue and the unpleasant aftertaste often associated with traditional oil-filled capsules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitux.